This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ucb Pharma, S.a.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Mark Ian Christie: Innovator in Multiple Sclerosis Treatment
Introduction
Mark Ian Christie is a notable inventor based in Newmarket, GB. He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis. His innovative approach focuses on inhibiting IL-17 activity, which has implications for improving the lives of those affected by this condition.
Latest Patents
Mark Ian Christie holds a patent for a method aimed at treating and/or preventing multiple sclerosis. The patent, titled "Method for the treatment of multiple sclerosis by inhibiting IL-17 activity," outlines a process that involves administering a therapeutically effective amount of an inhibitor of IL-17 activity. This invention represents a promising advancement in the therapeutic options available for managing multiple sclerosis.
Career Highlights
Throughout his career, Mark has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with UCB Pharma and UCB Biopharma. His experience in these organizations has allowed him to contribute to significant advancements in medical treatments.
Collaborations
Mark Ian Christie has collaborated with esteemed colleagues, including Stephen Edward Rapecki and Martyn Kim Robinson. These partnerships have fostered a collaborative environment that encourages innovation and the development of new therapeutic strategies.
Conclusion
Mark Ian Christie is a distinguished inventor whose work in the treatment of multiple sclerosis has the potential to make a lasting impact on patient care. His innovative methods and collaborations highlight the importance of research and development in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile